SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: vestor who wrote (1275)5/27/1999 9:10:00 PM
From: ubrx  Read Replies (1) of 1837
 
Vestor,
I wish I knew what kind of profit margin and market penetration they will achieve...but I don't. As Mr. Stewart mentioned if the DRMD product is priced cheaper than Zenith Goldline they will take market share. Hopefully, they will not get into a price war where margins are cut to an absurd level. IMO, there is room for Zenith and Duramed to both make some money on this product. It is a very big seller.

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext